HTLV-I screening in Britain.
作者信息
Pagliuca A, Pawson R, Mufti G J
出版信息
BMJ. 1995 Nov 18;311(7016):1313-4. doi: 10.1136/bmj.311.7016.1313.
Abstract
摘要
相似文献
1
HTLV-I screening in Britain.英国的人类嗜T淋巴细胞病毒I型筛查
BMJ. 1995 Nov 18;311(7016):1313-4. doi: 10.1136/bmj.311.7016.1313.
2
[HTLV-I antibody screening of blood donors].[献血者的人嗜T淋巴细胞病毒I型抗体筛查]
Beitr Infusionsther. 1991;28:29-31.
3
HTLV-I screening in Britain. Blood supply in Britain should be made safer.英国的人类嗜T淋巴细胞病毒I型筛查。英国的血液供应应更安全。
BMJ. 1996 Mar 16;312(7032):706.
4
Human T-lymphotropic virus infection: is it a threat?
Transplant Proc. 1996 Oct;28(5):2940.
5
HTLV-I screening in Britain. Antenatal screening is important.英国的人类嗜T淋巴细胞病毒I型（HTLV-I）筛查。产前筛查很重要。
BMJ. 1996 Mar 16;312(7032):706. doi: 10.1136/bmj.312.7032.706b.
6
HTLV-I infection in Britain.英国的人类嗜T淋巴细胞病毒I型感染。
BMJ. 1990 Jul 14;301(6743):71-2. doi: 10.1136/bmj.301.6743.71.
7
HTLV-I and blood safety: let the community decide.人类嗜T淋巴细胞病毒I型与血液安全：让社会来决定。
Med J Aust. 1997 May 5;166(9):454-5. doi: 10.5694/j.1326-5377.1997.tb123214.x.
8
HTLV-I--a screen too many?
Lancet. 1990 Nov 10;336(8724):1161.
9
Screening blood donors for HTLV-1: a case for a cost-benefit analysis.对献血者进行人类嗜T淋巴细胞病毒1型（HTLV-1）筛查：成本效益分析的一个实例
West Indian Med J. 1990 Sep;39(3):195-6.
10
Human T cell leukaemia/lymphoma virus and blood donation.人类T细胞白血病/淋巴瘤病毒与献血
BMJ. 1993 Nov 13;307(6914):1224-5. doi: 10.1136/bmj.307.6914.1224.
引用本文的文献
1
Prevalence of Human T Cell Leukaemia Virus amongst Blood Donors.献血者中人类T细胞白血病病毒的流行情况。
Med J Armed Forces India. 2009 Jan;65(1):38-40. doi: 10.1016/S0377-1237(09)80052-X. Epub 2011 Jul 21.
2
Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.尼日利亚埃努古献血者中人类T细胞淋巴瘤/白血病病毒1型（HTLV-1）抗体的血清流行率。
J Blood Med. 2015 Jan 19;6:31-6. doi: 10.2147/JBM.S65556. eCollection 2015.
3
Making British blood supply safer.保障英国血液供应安全。
BMJ. 1996 Jun 29;312(7047):1674. doi: 10.1136/bmj.312.7047.1674.
4
HTLV-I screening in Britain. Failure to screen may be a false economy.英国的人类嗜T淋巴细胞病毒I型（HTLV-I）筛查。不进行筛查可能是一种表面省钱却得不偿失的做法。
BMJ. 1996 Mar 16;312(7032):706-7.
5
HTLV-I screening in Britain. Blood supply in Britain should be made safer.英国的人类嗜T淋巴细胞病毒I型筛查。英国的血液供应应更安全。
BMJ. 1996 Mar 16;312(7032):706.
6
HTLV-I screening in Britain. Antenatal screening is important.英国的人类嗜T淋巴细胞病毒I型（HTLV-I）筛查。产前筛查很重要。
BMJ. 1996 Mar 16;312(7032):706. doi: 10.1136/bmj.312.7032.706b.
本文引用的文献
1
Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England.英格兰西米德兰兹郡HTLV-1感染血清流行率的产前调查。
Epidemiol Infect. 1993 Apr;110(2):379-87. doi: 10.1017/s0950268800068321.
2
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.伦敦北部献血者中人类T细胞白血病/淋巴瘤病毒抗体的流行情况。
BMJ. 1993 Nov 13;307(6914):1235-9. doi: 10.1136/bmj.307.6914.1235.
3
Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.法国献血者普遍筛查中HTLV-I/II的血清流行病学
AIDS. 1993 Jun;7(6):841-7. doi: 10.1097/00002030-199306000-00013.
4
HTLV screening of Swedish blood donors.瑞典献血者的人类嗜T淋巴细胞病毒筛查。
Lancet. 1995 Apr 15;345(8955):978. doi: 10.1016/s0140-6736(95)90721-1.
5
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.选择献血者与随机献血者抗人嗜T淋巴细胞病毒I型抗体筛查的效果比较
Vox Sang. 1995;68(4):251-2. doi: 10.1111/j.1423-0410.1995.tb02584.x.
6
Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.用于筛查献血者的HIV-1/2与HTLV-I/II联合检测方法的评估
Vox Sang. 1995;68(4):220-4. doi: 10.1111/j.1423-0410.1995.tb02576.x.
7
A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.成人T细胞白血病病毒输血传播的回顾性研究：受血者血清阳转情况
Vox Sang. 1984;46(5):245-53. doi: 10.1111/j.1423-0410.1984.tb00083.x.
8
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.
Lancet. 1982 Mar 20;1(8273):639-43. doi: 10.1016/s0140-6736(82)92200-0.
9
Blood transfusion and HTLV-I associated myelopathy.输血与人类嗜T淋巴细胞病毒I型相关脊髓病
Lancet. 1986 Jul 12;2(8498):104-5. doi: 10.1016/s0140-6736(86)91636-3.
Zotero 插件